Both CGT’s fresh and cryopreserved leukopaks work well for CAR T, but the difference is what they optimise for. Here is a guide to help you choose the right one for you.
Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing
KACTUS: CAR-T Target Antigens
KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.
Analytical Tools
All the analytical tools you need for your research: in vivo products, tetramers, ELISAs, small molecules & proteins (RUO & GMP)!
Chimeric Antigen Receptor (CAR) T Cell Therapy
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
The Dark Side of CAR-T Therapy – Cytokine Release Syndrome (Diaclone)
Immunotherapies such as monoclonal antibodies, bispecific antibodies (Bi-specific T-cell engagers or BiTEs) and adoptive T-cell therapies (e.g. CAR-modified T-cell) have provided great advances in cancer treatment. However, testing new therapies is not without risk. The most common and potentially severe